Tsai, Hui-Jen
Shan, Yan-Shen
Yang, Ching-Yao
Hsiao, Chin-Fu
Tsai, Chung-Hsin
Wang, Chuan-Cheng
Lin, Ming-Tsan
Ting, Chun-Fu
Chan, De-Chuan
Chen, Te-Hung
Yen, Chueh-Chuan
Chen, Yen-Yang
Lin, Hsuan-Yu
Yeh, Ta-Sen
Ho, Ching-Liang
Shieh, Tze-Yu
Bai, Li-Yaun
Hsu, Jun-Te
Chen, I-Shu
Chen, Li-Tzong
Yeh, Chun-Nan
Liu, Tsang-Wu
Chuang, Chieh-Han
Wang, Tsang-En
,
Article History
Received: 5 October 2023
Accepted: 26 June 2024
First Online: 11 July 2024
Declarations
:
: The study protocol was reviewed and approved by the Institutional Review Board (IRB) of each participating institution, including National Taiwan University Hospital Ethics Center Research Ethics Section, Institutional Review Board, Taipei Veterans General Hospital, the Institutional Review Board of Tri-Service General Hospital, Mackay Memorial Hospital IRB, Chang Gung Medical Foundation Institutional Review Board, China Medical University Hospital Research Ethics Committee, Institutional Review Board of Changhua Christian Hospital, National Cheng Kung University Hospital IRB, Kaohsiung Medical University Hospital IRB, and Department of Medical Education and Research Kaohsiung Veterans General Hospital. All patients except those who had died signed informed consent.
: Not applicable.
: Dr. Li-Tzong Chen has received research funding from Pfizer to National Health Research Institutes. All other authors declare no financial conflicts of interest.